Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.127,61
0,54%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aerpio Pharmaceuticals Inc (ARPO) Aerpio Pharmaceuticals Inc (ARPO) Notizie

ARPO

Aerpio Pharmaceuticals (ARPO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARPO
DataOraFonteTitoloSimboloCompagnia
21/06/202312:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
16/06/202321:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/04/202319:25Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/04/202318:47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/04/202318:43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202322:19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202322:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202312:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/03/202322:08Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
14/02/202312:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
09/11/202222:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARPOAerpio Pharmaceuticals Inc
07/11/202212:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARPOAerpio Pharmaceuticals Inc
04/11/202221:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
26/10/202222:50Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
11/10/202218:28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ARPOAerpio Pharmaceuticals Inc
04/10/202222:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARPOAerpio Pharmaceuticals Inc
26/09/202223:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
21/03/202211:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARPOAerpio Pharmaceuticals Inc
07/09/202123:26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ARPOAerpio Pharmaceuticals Inc
01/09/202101:53Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
09/07/202113:31TipRanksPenny Stock Aerpio Pharmaceuticals’ Merger With Aadi Makes It A Buy, Says AnalystNASDAQ:ARPOAerpio Pharmaceuticals Inc
21/06/202113:31Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
17/09/202013:00GlobeNewswire Inc.Aravive Appoints Michael W. Rogers to Board of DirectorsNASDAQ:ARPOAerpio Pharmaceuticals Inc
01/09/202022:30PR Newswire (US)Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-...NASDAQ:ARPOAerpio Pharmaceuticals Inc
27/05/202022:30PR Newswire (US)Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation ...NASDAQ:ARPOAerpio Pharmaceuticals Inc
12/05/202022:30GlobeNewswire Inc.Aerpio Announces Amended Licensing Deal with Gossamer Bio on its Inflammatory Bowel Disease (IBD) Product Candidate GB004 (fo...NASDAQ:ARPOAerpio Pharmaceuticals Inc
17/04/202022:46Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
12/03/202022:00GlobeNewswire Inc.Aerpio Pharmaceuticals to Report Year Ended December 31, 2019 Financial Results on Monday, March 16, 2020NASDAQ:ARPOAerpio Pharmaceuticals Inc
08/02/202000:20Business WireAerpio Pharmaceuticals Presents Data from Fifth Patient Cohort Showing Potential of Topical Ocular Formulation of AKB-9778 Pr...NASDAQ:ARPOAerpio Pharmaceuticals Inc
08/01/202014:43Business WireTopical Ocular Formulation of Aerpio Pharmaceutical’s AKB-9778 Product Candidate Produced IOP Lowering with Minimal Hyperem...NASDAQ:ARPOAerpio Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARPO

La tua Cronologia

BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
BFF
BFF Bank
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
MB
Mediobanca Banca di Cred...
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network